Entering text into the input field will update the search result below

Embraer: 41% Upside As Vaccinations Speed Up In America And Europe

Apr. 12, 2021 8:52 AM ETEmbraer S.A. (ERJ)12 Comments
Andreas Repeta profile picture
Andreas Repeta


  • North America and Europe are likely to reach herd immunity by the end of 2021. 81.5% of Embraer's revenue streams come from these regions.
  • Target price of $15.94 by the end of 2021 seems reasonable, 41% upside from current levels.
  • Key risks include new circulating COVID-19 variants and sustained international travel restrictions.

n Embraer ERJ 145 passagerarflygplan av American Eagle Airlines är fallande för att landa på Ronald Reagan National Airport.
Photo by Grandbrothers/iStock Editorial via Getty Images


Geographical segmentation of revenue shows that 81.5% of Embraer's (NYSE:ERJ) revenue originates from North America and Europe. Extrapolating on current vaccination rates, it is likely that North America and Europe will reach herd

This article was written by

Andreas Repeta profile picture
BSc in Business & Economics.I am an avid follower of markets and mainly write long analyses of equities. Particularly interested in macroeconomics, geopolitics, and applying a topdown-view of markets. Specialized in analyzing market share and potential monopolistic, duopolistic, and oligopolistic market scenarios.andreas.repeta@eastinvest.org

Analyst’s Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.